Skip to content

Clinical trials

Phase 2 Cardiomyopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 2 Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20051
20081
20102
20124
20131
20141
20151
20163
20182
20203
20211
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting6
Terminated3
Unknown status3
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capricor Inc.2
Alnylam Pharmaceuticals1
Amphia Hospital1
Annetine Gelijns1
Assistance Publique - Hôpitaux de Paris1
Bambino Gesù Hospital and Research Institute1
Bayer1
Brigham and Women's Hospital1
Celladon Corporation1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies29
Heart Failure11
Cardiomyopathy, Dilated3
Cardiomyopathy, Hypertrophic3
Heart Diseases3
Alzheimer Disease2
Amyloidosis2
Cardiomegaly2
Cardiovascular Diseases2
Hypertrophy, Left Ventricular2

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.